Bayer
New activities and developments reported by Bayer
Published in Health Business Week, November 24th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Bayer.
Report 1: Bayer HealthCare, a member of the Bayer Group (BAY), announced findings from a study using Bayer Diagnostics' Serum HER-2/neu test that demonstrated metastatic breast cancer (MBC) patients whose serum HER-2/neu levels decreased by less than 20% experienced decreased benefit from trastuzumab-based therapy.
The data, from a pooled analysis of seven clinical trials in the United States and western Europe of MBC patients who received trastuzumab (with or without...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-11-24)
More Articles from Health Business Week
- Abdominal Aortic Aneurysms
Endologix announces favorable Powerlink five-year follow-up data at TCT 2006 Conference - Acute Myeloid Leukemia
Lorus presents GTI-2040 pharmacokinetic and metabolic data in acute myeloid leukemia - Allergy & Immunology
Altana Pharma receives approval to market Ciclesonide nasal spray in the U.S. - Allergy & Immunology
SAFC appointed by Curalogic to provide chemical development services - Antibacterial Agents
Pneumonia germ cell wall can damage heart, brain cells - Antibacterial Agents
U.S. Food and Drug Administration issues non-approvable letter to Replidyne for faropenem - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
